I have a flow system

Chapter 317: Protect fiercely!

As stated in the open letter to the outside world.

Aiying Company, or in other words, Wu Zhou has already made relevant plans!

Although it seems that Aiying Group has received similar treatment to Juchang, and in terms of business proportion, it is actually similar, and the foreign proportion is not small!

However, the technological content of Aiying Group's products is still much lower than that of Juchang!

However, after all, the Aiying Group was established only a few years ago, and the Chrysanthemum Factory has been around for many years!

Secondly, the fields that Juchang is involved in, some subdivisions, are much more than Wu Zhou’s!

Of course, if the scope is limited to those fields that Aiying Group is involved in, Wu Zhou's Aiying Company must be at the global leading level in terms of software strength!

In terms of hardware, even if it is not the world leader, it can at least be the first in the world!

Wu Zhou spends tens of billions of money a year, coupled with the research and development integration of AI technology, coupled with Wu Zhou’s system help, and then talents from all walks of life gather together!

Etc., etc., etc., etc., etc., many project results have not been fully released yet. If they are all released,

Even in some fields, some old companies have first-mover advantages and have obtained some necessary patent restrictions.

But the Aiying Group is not without countermeasures! '

In general, Wu Zhou is not worried about being sanctioned at all!

On the contrary, I even said that I was very happy to see this result!

This is the most powerful country in the world. How about giving his company a free super advertisement?

The greater their momentum and the greater the movement, the higher the Aiying Group's global reputation will be!

This is also the reason why the global online media immediately went crazy after they imposed severe sanctions!

This spread speed is many times faster than when it was first spread in Juchang!

Then, as a company that is written on a small book and is targeted by world powers, "How can you still say that it has no technology? How can a company with no technology and no threats be written on a small book?"

Therefore, during this wave, coupled with the virus period, Aiying Group’s related products have formed a good reputation among consumers around the world!

Taken together

A subconscious thought has been initially formed: "Aiying Group is a relatively powerful technology company in China! Their technology is very good!"

As the news spread rapidly, Wu Zhou also received calls from some leaders one after another!

The leader of his hometown province gave Wu Zhou a call!

The general idea is that they are also paying attention to international affairs and whether there will be changes to the projects that were previously discussed. This is a special situation and they can adjust some contract details if there are changes!

Wu Zhou's reply was, "Thank you for your concern, leadership. This matter is not important! Just execute the contract as usual!"

On the other hand, some departments in Beijing are analyzing the reasons for the United States.

Of course, the focus is also on analysis, how big is the 'threat coefficient' of the Aiying Group!

Huaxia is so big that even though Aiying Group has a revenue of hundreds of billions, the higher-ups still can’t control it, or they haven’t fully noticed it.

Just like a sentence in the second volume of Selected Works of Mao!

"We must support whatever the enemy opposes; whatever the enemy supports, we must oppose it!"

This time, Aiying Group has come into the sight of leaders!

"I really didn't expect that this Xiao Wu would do so many things quietly!"

Wu Zhou's company has already entered the vision of some people at the top!

It’s just that at the beginning, Wu Zhou was too young, and he was still working in areas with little technical content, such as food supplies.

So the impression the upper management has of him is that he is a young entrepreneur who has a certain sense of family and country and is very energetic. As for his products,

Although the food is pretty good, the ones used for food don’t actually have much influence! There are too many similar companies. Even if the quality of Aiying Group's related products reaches the top in the industry, so what?

Later, Wu Zhou got involved in the field of biomedicine, invested heavily, and quickly developed the corresponding virus vaccine. This was an unexpected surprise.

After all, there are many companies in China that can make related inactivated biological vaccines! There is not much technical difficulty!

Therefore, the Aiying Group still does not pay much attention. The most is that Wu Zhou is willing to greatly cooperate with the country in terms of relevant interests, and even transfer all interests. This makes the upper management's favor towards Wu Zhou even greater!

It even gives a certain degree of preferential treatment!

I am also curious about what Wu Zhou can do in the future.

What I didn’t expect was that this future would come so quickly!

After really careful investigation, I discovered that these people were somewhat dark under the light.

The survey data from a few months ago and the survey data on hand now have undergone earth-shaking changes!

For example, in the area of ​​operating systems, China has developed so many independent operating systems, and many companies have made some achievements. However, after so many years, Wu Zhou's Aiying actually did it directly and silently. The best place ever!

Another example is AI. China's AI has actually been developing, but it is more on the application side, that is, in the industrial field. It is mainly used to improve production efficiency!

But what I didn't expect was that Aiying Group actually made major breakthroughs in generative AI and industrial AI, directly entering the world's leading position. According to the report they have, Aiying Group’s AI technology has been applied to all aspects of their company’s operations, such as R&D design planning, quality inspection, equipment predictive maintenance, production process control, operation management optimization, product service optimization, etc.!

The effects are very good!

To give the most direct example, based on revenue comparison!

For example, Nongfu Spring’s revenue last year was 200 billion, but its total employees were less than 2.

Moutai's revenue is less than 1000 billion, and its total number of employees is just over 4.

As for Aiying Group, it has a revenue of 3000 billion+ and a total number of employees of less than 2.

The revenue created by a single employee is more than 6 times that of Moutai employees! It is more than 15 times that of Wahaha employees.

If you look at it from another perspective, don’t compare with companies in the retail industry.

Compared with Juchang, Juchang has a total revenue of about 2020 billion in 9000 and a total number of employees of about 20.

The average revenue generated by one employee of Aiying Group is more than three times that of Juchang

However, there is still a slight gap between it and the world's top companies.

For example, Apple

In 2020, the total revenue will be approximately US$2700 billion, and the total number of employees will be approximately 6!

The revenue generated by a single employee is about twice that of Aiying Group!

But Apple is number one in the world after all? And another practical situation must be considered. Aiying Group’s revenue is calculated in RMB, while Apple’s revenue is calculated in US dollars!

And as time goes by, when China's national power becomes stronger, the strength of the RMB will inevitably come!

Of course, don’t consider these now, even if it’s just based on the current situation!

According to the current development speed of Aiying Group, continue.

In 2021, which scientific and technological achievements will further develop and even gradually enter the stage of realization?

What will happen to Aiying Group?

When reading further down the information.

There are more and more surprises! The expressions on everyone's faces are getting richer and richer.

The smile on his face can’t even be concealed!

Biomedical field!

Although Aiying Biotech has only entered this industry for one year.

However, R&D investment last year reached 157 billion yuan, which is much higher than the level of China's industry. The total number of R&D team members has also rapidly soared to more than 3900 people, of which more than 1200 have doctorates and more than 200 have overseas study or work experience!

In the past year, these people have screened more than 10 potential compounds through Aiying Group's AI technology, of which more than 3000 have been verified to have drug activity, involving more than 100 drug targets.

During the same period, their company also published 297 high-level research papers in internationally renowned magazines such as Cell, Nature, and The Lancet!

If you don’t have any idea just by looking at this data, it will become clearer if you make a comparison object.

Huaxia's ranking of medical institutions publishing high-level international journal articles in 2020 is ranked first by West China, with a total of 319 related papers published!

Followed by Xiehe, with a total of 120 articles!

In other words, with only 22 papers missing, Aiying Biopharmaceutical Company can directly become the first in China in terms of the number of papers published! .

However, most biopharmaceutical companies do not publish academic papers frequently. They focus more on drug research and development, clinical trials and commercialization.

Therefore, whether a pharmaceutical company's research results are strong or not is more reflected in patents, clinical data, and drug launches.

And in this regard!

Aiying Group also performs well. Ranking of invention patents in the global biomedical industry, the total number of applications in 2020 is 251. For comparison, the first place in China is Hengrui with 536 applications, the second place is Wuxi AppTec with 306 applications, and the third place is Zhengda Tianqing has 287 cases, and Aiying Biomedicine ranks fourth in China!

Of course, if you only look at these and then consider the establishment time of Aiying Biotech, you will feel that Wu Zhou's biopharmaceutical company is blindly brushing data!

After all, pharmaceutical research and development is not a 'quick-turn' field!

Then I saw it.

Aiying Biopharmaceutical Company has also made major breakthroughs in the field of rare diseases and severe diseases. It has developed a total of 36 new active substances, 16 of which have obtained priority review qualifications from the National Medical Products Administration, and 6 have obtained U.S. Five products have received breakthrough therapy designation from the Food and Drug Administration and obtained orphan drug status from the European Medicines Agency.

Generally speaking, orphan drugs and breakthrough drugs for rare and serious diseases can apply for priority review and enjoy various benefits, such as prioritizing review resources and shortening the review time limit, which is generally half or a quarter of the regular review time limit. one. Prioritize registration inspections and verifications, and simplify inspection and verification procedures and requirements. Prioritize administrative approval, speed up the issuance and publicity of administrative licenses, prioritize post-market monitoring, and provide post-market support and services.

If nothing else happens, maybe in just three to five years, Aiying Biopharmaceutical Company will have a series of "independent property rights and world-leading" drugs on the market!

But is this all?

Medical devices

Manufacturing upgrade, environmental protection, green energy, modern agriculture, elderly care.

The more I look at it, the more surprised I am, and the more I look at it, the more surprised I am!

I'm so surprised, I must 'protect' such talents! ! !

(End of this chapter)